Heart Disease News and Research

Latest Heart Disease News and Research

MEDNAX reports revenue growth of 17.3% to $555M

MEDNAX, Inc., the national medical group specializing in neonatal, maternal-fetal, pediatric cardiology, other pediatric subspecialties and anesthesia physician services, today reported earnings of $1.52 per share for the three months ended September 30, 2013 resulting from strong revenue growth, primarily from recent acquisitions.

31 Oct 2013

Researchers explore strategies that would optimize fresher blood for patients

Although clinical evidence is lacking on the relationship between the storage time of red blood cells and outcomes in transfused patients, the authors of a review article in the November 2013 issue of The Annals of Thoracic Surgery are advocating for a modernized blood management system—similar to inventory management systems seen in the retail sector—to potentially reduce patient complications.

31 Oct 2013

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

Protego Medical Pty Ltd, an early stage medical technology company developing a medical device for sternal protection during cardiac surgery, was launched today with AU$2M start-up financing from Australia’s Medical Research Commercialisation Fund (MRCF). At the same time, the Company announced the appointment of Pablo Solis as CEO.

31 Oct 2013

Kamada announces new data from Glassia Phase I/II study in pediatric patients with type 1 diabetes

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, today reported preliminary data from the Company's ongoing extension study of a Phase I/II clinical trial with its lead product Glassia® to treat pediatric patients with a recently diagnosed type 1 diabetes (T1D).

31 Oct 2013

Websites targeting veterans fail to provide information about risks of tobacco products

Studies have shown that U.S. military veterans smoke at a higher rate than civilians. Websites targeting veterans, however, fail to provide information about the risks of tobacco products and how to quit smoking, finds a new report in the American Journal of Health Promotion.

31 Oct 2013

Results of Nordic-Baltic Bifurcation IV trial presented at TCT 2013

A new clinical trial shows that a two-stent technique for treatment of bifurcation lesions with a large stenotic side branch was not associated with significant improved outcomes compared to a provisional stenting approach.

31 Oct 2013

"Good" cholesterol improves blood glucose levels, say scientists

High density lipoprotein cholesterol (HDL), the so-called "good" cholesterol improves blood glucose levels by enhancing skeletal muscle function and reducing adiposity, scientists of the Helmholtz Zentrum München report in the current issue of the renown American Heart Association Journal ‚Circulation'.

31 Oct 2013

New strategy for emergency anticoagulant treatment for patients with myocardial infarction

A new strategy for emergency anticoagulant treatment for patients with acute myocardial infarction has been put in place by a team led by Philippe-Gabriel Steg at Inserm Unit 698 (Haemostasis, Bioengineering, Immunopathology and Cardiovascular Remodelling), at H-pital Bichat, AP-HP, Universit- Paris Diderot).

31 Oct 2013

New discovery unveils unequal geographic distribution of PCI capacity for treating heart attack patients

A multi-center team led by James Langabeer II, Ph.D., of The University of Texas Health Science Center at Houston (UTHealth) has published a first-of-its-kind study in the Journal of the American Heart Association (JAHA) that examines unequal growth in percutaneous coronary intervention (PCI) centers relative to population and heart attack prevalence across the United States.

31 Oct 2013

HIV infection, not antiretroviral therapy associated with risk for atherosclerosis

HIV infection, not antiretroviral therapy (ART), is associated with risk for atherosclerosis in patients with no history of smoking, particularly those infected for eight years or more.

31 Oct 2013

Meclizine drug has the potential to treat certain infectious diseases and cancer

Meclizine, an over-the-counter drug used for decades to treat nausea and motion sickness, has the potential for new uses to treat certain infectious diseases and some forms of cancer, according to Dr. Vishal M. Gohil, Texas A&M AgriLife Research biochemist.

31 Oct 2013

UofL researcher enters into license and research collaboration agreement with Novartis

The University of Louisville today announced that researcher Dr. Suzanne Ildstad, representing Regenerex LLC, has entered into a license and research collaboration agreement with Novartis to provide access to stem cell technology that has the potential to help transplant patients avoid taking anti-rejection medicine for life and could serve as a platform for treatment of other diseases.

31 Oct 2013

Parental bipolar history common in US bipolar patients

Research findings suggest that patients with bipolar disorder who reside in the United States have a higher parental incidence of bipolar disorder and depression than those who live in Europe.

30 Oct 2013

Extra input pays bipolar treatment dividends

Customizing an implementation program to individual practices and providing proactive support improves the adherence of patients with bipolar disorder to Life Goals Collaborative Care, shows a randomized trial.

30 Oct 2013

Mediterranean diet exerts greater cardioprotective effect than low-fat diet, shows study

The Nutrition and Obesity Research Group of the UPV/EHU-University of the Basque Country is studying the effects of diet composition on people's body weight and health. Its participation in the PREDIMED project features among the many pieces of research it has conducted.

30 Oct 2013

Inaugural "Leadership" award presented to co-founder of Anytime Fitness

Chuck Runyon, CEO and co-founder of Anytime Fitness, the world's fastest-growing gym, has been presented with an inaugural "Leadership" award by Chief Executive magazine.

30 Oct 2013

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

A multidisciplinary team of experts in heart failure, cardiac arrhythmia, and neurosurgery at The Mount Sinai Hospital are now testing nerve stimulation in the neck as a novel therapy for heart failure patients to potentially help relieve their debilitating symptoms of fatigue, shortness of breath, and heart arrhythmias, while reducing their hospitalizations.

30 Oct 2013

HDL-like particles could someday be used to combat atherosclerosis

A new type of "good cholesterol," made in the lab, could one day deliver drugs to where they are needed in the body to treat disease or be used in medical imaging, according to scientists.

30 Oct 2013

Eliza's Star multi-modal programs address gaps in healthcare

Eliza Corporation ("Eliza"), the pioneer and recognized leader in Health Engagement Management, today announced "Star 2014", a proactive member communication solutions suite that addresses key areas of the Centers for Medicare & Medicaid Services (CMS) Star programs.

30 Oct 2013

CME Medical helps healthcare professionals to gain confidence in end of life and palliative care

CME Medical, is helping healthcare professionals to gain confidence in caring for patients at the end of their lives. Managing end of life care is a challenge for all health staff, as it often involves dealing with complex and emotional communication with patients and relatives and managing patient symptoms. But now highly sophisticated mannequins – which can talk and simulate signs and symptoms of advanced illness – are being used in a pioneering and unique training programme in Birmingham.

30 Oct 2013

Heart Disease News and Research

Latest Heart Disease News and Research

MEDNAX reports revenue growth of 17.3% to $555M

Researchers explore strategies that would optimize fresher blood for patients

Protego develops sternal device for cardiac surgery with start-up investment from MRCF

Kamada announces new data from Glassia Phase I/II study in pediatric patients with type 1 diabetes

Websites targeting veterans fail to provide information about risks of tobacco products

Results of Nordic-Baltic Bifurcation IV trial presented at TCT 2013

"Good" cholesterol improves blood glucose levels, say scientists

New strategy for emergency anticoagulant treatment for patients with myocardial infarction

New discovery unveils unequal geographic distribution of PCI capacity for treating heart attack patients

HIV infection, not antiretroviral therapy associated with risk for atherosclerosis

Meclizine drug has the potential to treat certain infectious diseases and cancer

UofL researcher enters into license and research collaboration agreement with Novartis

Parental bipolar history common in US bipolar patients

Extra input pays bipolar treatment dividends

Mediterranean diet exerts greater cardioprotective effect than low-fat diet, shows study

Inaugural "Leadership" award presented to co-founder of Anytime Fitness

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

HDL-like particles could someday be used to combat atherosclerosis

Eliza's Star multi-modal programs address gaps in healthcare

CME Medical helps healthcare professionals to gain confidence in end of life and palliative care

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Heart Disease News and Research

Latest Heart Disease News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in